ACB $10.270 (-0.39%)

ACNNF $0.107 (-7.94%)

AERO $4.490 (-0.22%)

AGEEF $0.090 (6.41%)

ALEAF $0.435 (-1.65%)

AMMJ $0.108 (-6.09%)

APHA $4.470 (-4.08%)

ARNA $63.270 (-2.1%)

ATT:CNX $0.080 (0%)

ATTBF $0.008 (4.17%)

AUSA:CNX $0.170 (-5.56%)

AUSAF $0.131 (-0.41%)

AVXL $4.200 (-0.94%)

BAMM:CNX $0.335 (3.08%)

BBM:CNX $0.055 (10%)

BBRRF $0.044 (0.23%)

BE:CNX $0.005 (0%)

BIO:CNX $0.080 (0%)

BLEVF $0.005 (13.64%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.510 (5.15%)

BLOZF $0.388 (4.73%)

BUDZ $0.263 (-1.69%)

BXNG $0.530 (1.92%)

CADMF $0.700 (-2.53%)

CALI:CNX $0.115 (43.75%)

CANN $0.410 (2.95%)

CARA $16.950 (-0.18%)

CBII:CNX $0.125 (8.7%)

CBIIF $0.090 (12.25%)

CBWTF $0.178 (1.43%)

CGC $16.630 (-5.08%)

CGRW $0.087 (5.97%)

CHOO:CNX $0.110 (10%)

CHOOF $0.081 (9.26%)

CNBX $0.200 (4.55%)

CNGGF $0.310 (2.34%)

CODI $17.290 (1.59%)

CPMD $2.220 (13.85%)

CRBP $6.610 (4.42%)

CRON $5.640 (-3.92%)

CROP:CNX $0.015 (0%)

CRTPF $1.650 (-2.94%)

CRXPF $0.025 (-16.67%)

CSI:CNX $0.920 (0%)

CURR $1.610 (0.63%)

CVSI $0.643 (-5.44%)

DIGP $0.035 (0%)

DXBRF $0.140 (0%)

EAPH $0.001 (12.5%)

EAT:CNX $0.025 (0%)

EEVVF $0.051 (-7.05%)

EMHTF $0.141 (-3.37%)

EPWCF $0.040 (9.64%)

EVIO $0.019 (-1.76%)

FFRMF $0.028 (-9.68%)

FFT:CNX $0.040 (0%)

FNNZF $0.075 (9.27%)

GGTTF $0.090 (0%)

GLDFF $0.019 (0%)

GLH:CNX $0.020 (-20%)

GNBT $0.410 (-8.89%)

GRIN:CNX $0.120 (-4%)

GRWG $9.030 (3.91%)

GSTR:CNX $0.090 (-5.26%)

GTBIF $14.350 (-0.62%)

GTII:CNX $19.170 (-0.1%)

GWPH $109.370 (-17.21%)

HEXO $0.689 (-1.25%)

HHPHF $0.006 (0%)

HLSPY $0.474 (8.96%)

HMLSF $5.060 (-4.07%)

HMPPF $0.498 (0%)

HRVOF $0.062 (2.83%)

HSTRF $0.101 (-4.61%)

HUGE:CNX $4.080 (2%)

IAN:CNX $0.305 (0%)

IGC $0.705 (0.18%)

IGXT $0.207 (-2.64%)

IIPR $114.630 (3.11%)

IMLFF $5.260 (-7.72%)

INQD $0.004 (35.71%)

IONC:CNX $0.015 (0%)

IONKF $0.017 (0%)

ISOL:CNX $0.050 (-9.09%)

ISOLF $0.041 (0.73%)

ITHUF $0.059 (-1.67%)

IVITF $0.013 (0%)

JWCAF $0.003 (-65.56%)

KALTF $0.001 (0%)

KBEV:CNX $0.070 (0%)

KBEVF $0.053 (-6.91%)

KHRNF $0.362 (-2.14%)

KSHB $0.670 (-3.6%)

LHS:CNX $0.500 (0%)

LHSIF $0.373 (0.7%)

LOVE:CNX $0.100 (5.26%)

LXRP $0.400 (1.55%)

LXX:CNX $0.530 (1.92%)

MCIG $0.028 (0%)

MEDIF $0.755 (0.95%)

MGWFF $0.057 (-4.18%)

MICWF $0.052 (0%)

MJ:CNX $0.035 (0%)

MJNA $0.014 (1.06%)

MNTR $0.079 (-15.96%)

MRRCF $0.004 (5.56%)

MWM:CNX $0.070 (7.69%)

MYM:CNX $0.065 (-7.14%)

MYMMF $0.052 (-2.72%)

NCNNF $0.130 (-6.47%)

NDVAF $0.220 (-1.48%)

NGW:CNX $0.225 (-19.64%)

NRXCF $0.106 (5.72%)

NSPDF $0.050 (-2.59%)

NTEC $0.420 (8.03%)

NVTQF $0.451 (0%)

NWKRF $0.424 (0%)

NXGWF $0.169 (-19.08%)

NXTTF $0.220 (3.43%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

OWCP $0.009 (1.09%)

PHCG $0.460 (2.22%)

PHVAF $0.040 (-4.76%)

PILL:CNX $0.650 (-7.14%)

PKG:CNX $0.095 (0%)

PLPRF $0.470 (4.68%)

PLUS:CNX $0.600 (-1.64%)

PMCB $0.015 (5%)

PNPL $0.280 (0%)

POTN $0.015 (-6.65%)

PRCNF $0.016 (60%)

PTNYF $0.067 (-6.23%)

QCA:CNX $0.110 (0%)

RDDTF $0.107 (0.38%)

RLLVF $0.024 (-15.18%)

RMHB $0.034 (6.88%)

RQB:CNX $0.005 (0%)

RQHTF $0.197 (0.77%)

RVVQF $0.015 (3.45%)

SLNG:CNX $0.135 (-3.57%)

SMG $158.470 (1.09%)

SNN:CNX $0.155 (0%)

SNNVF $0.120 (0%)

SOL:CNX $0.385 (2.67%)

SOLCF $0.298 (4.47%)

SPLIF $0.017 (-0.52%)

SPRWF $0.165 (6.49%)

SRNA $0.045 (7.22%)

STEM:CNX $0.460 (-8%)

STMH $0.414 (1%)

SUN:CNX $0.155 (-3.13%)

TBPMF $0.155 (-0.45%)

TCAN:CNX $1.220 (0%)

TCNAF $0.900 (0%)

TER:CNX $4.950 (-1%)

TGEN $0.850 (4.94%)

TGIF:CNX $0.060 (-7.69%)

TGIFF $0.048 (-1.45%)

THC:CNX $0.170 (-2.86%)

THCBF $0.126 (-4.18%)

TLRY $7.460 (-3.87%)

TOKI:CNX $0.030 (0%)

TRLFF $0.031 (18.85%)

TRSSF $3.700 (-0.54%)

TRTC $0.083 (-0.12%)

TURV $0.107 (-0.56%)

VBIO $0.132 (-26.67%)

VIDA:CNX $0.050 (-9.09%)

VIN:CNX $0.030 (20%)

VPRB $0.008 (1.25%)

VRNDF $0.470 (4.44%)

VRT:CNX $0.145 (0%)

VRTHF $0.125 (5.49%)

VVCIF $0.186 (0.38%)

WAYL:CNX $0.740 (0%)

WDDMF $0.271 (-0.7%)

WLDFF $0.127 (5.92%)

XXII $0.730 (-1.55%)

ZDPY $0.150 (7.14%)

ZYNE $4.220 (-1.86%)

Back

Emerald Organic Products Is A Multifaceted Healthcare Company Investors Should Be Watching

May 7, 2020 • 7:25 AM EDT
2 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Last month, we published an article that highlighted Emerald Organic Products, Inc. (OTC: EMOR) and received a lot of positive feedback on the opportunity. We believe that Emerald Organic Products represents an emerging diversified health sciences company that is focused on a number of high-growth verticals and is flying under the radar.

The last few months have been busy for Emerald Organic Products and we are favorable on how the story has advanced during this time. From strengthening the balance sheet to announcing strategic partnerships and acquisitions, we are bullish on the growth prospects associated with the opportunity and believe that it is an opportunity to be watching.

Download Your In Depth Report Here

Emerald Organic Products has been highly focused on the cannabis industry and recently announced agreements that would provide it leverage to the coronavirus testing and telemedicine markets. The company is a diversified health sciences company that is focused on providing consumers with proprietary health and wellness products. Through its subsidiaries, Emerald is dedicated to improving access to holistic and Food & Drug Administration (FDA)-regulated products and services.

We believe that Emerald Organic Products has an attractive operating structure and are of the opinion that the market underappreciates the growth prospects that are associated with it. Going forward, we expect the business to report strong growth and are closely monitoring it for the following reasons:

  1. Emerald Organic Products has attractive growth prospects and is focused on several high growth verticals
  2. The company has strengthened its balance sheet and is well positioned to execute on previously announced initiatives
  3. Emerald Organic Products is led by a management team that has its finger on the pulse of the market and has been able to identify unique growth opportunities
  4. At current levels, we believe that the company has a favorable risk-reward profile and has significant potential catalysts for growth

Download Our In Depth Report Here

 

 

 

 

Pursuant to an agreement between StoneBridge Partners LLC and Emerald Organic Products Inc. (EMOR) we have been hired for a period of 180 days beginning January 13, 2020 and ending July 13, 2020 to publicly disseminate information about (EMOR) including on the Website and other media including Facebook and Twitter. We are being paid $6,500 per month (EMOR) for or were paid “0” shares of restricted common shares. We own zero shares of (EMOR), which we purchased in the open market. We plan to sell the “ZERO” shares of (EMOR) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (EMOR) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Share Share - Facebook Share - Twitter

Tags

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Comments

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Technical420 newsletter.

 All good -- no spamming here.